Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | TRAIL | 33.5 | 50 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 4 | TRAIL | 35.0 | 61 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | TRAIL | 61.0 | 66 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | TRAIL | 59.0 | 79 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | TRAIL | 55.0 | 68 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | TRAIL | 57.0 | 69 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | TRAIL | 57.5 | 74 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | TRAIL | 51.5 | 58 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | TRAIL | 62.0 | 59 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | TRAIL | 57.0 | 49 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | TRAIL | 59.0 | 73 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | TRAIL | 51.0 | 66 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | TRAIL | 55.0 | 53 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | TRAIL | 51.5 | 46 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | TRAIL | 30.0 | 67 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | TRAIL | 29.0 | 88 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | TRAIL | 29.0 | 68 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | TRAIL | 25.5 | 76 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | TRAIL | 32.0 | 81 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | TRAIL | 30.0 | 61 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | TRAIL | 30.0 | 77 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | TRAIL | 31.0 | 71 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | TRAIL | 28.5 | 72 | |
N2645 | TNF-a | 100 | ng/mL | 4 | TRAIL | 30.0 | 77 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | TRAIL | 32.5 | 60 |